Forte Biosciences, Inc. [FBRX]

Source: 

Company Overview

Forte Biosciences, Inc. and its subsidiary (collectively the Company, Forte, we, or us,)is a clinical-stage biopharmaceutical company focused on advancing through clinical trials our lead product candidate,FB-401,which is a topically applied, non-steroidal, live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis (AD). There is currently a significant unmet need for safe and effective therapies for pediatric AD patients. FB401 was developed in collaboration with the National Institutes of Health (NIH), and the National Institute of Allergy and Infectious Diseases (NIAID).